单胎妊娠胎儿生长受限的危险因素及其对胎儿结局的影响

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (969 KB) HTML (0 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the risk factors of fetal growth restriction (FGR) in single pregnancy and its influence on fetal outcomes. Methods The clinical data of 375 single pregnancies with FGR admitted to the First Medical Center of PLA General Hospital from January 2018 to December 2022 were retrospectively analyzed and set as the study group, and 375 clinical data of single pregnancies without FGR were also collected through stratified sampling and set as the control group. Maternal factors, fetal accessory factors, delivery modes and fetal outcomes were compared between the two groups, the risk factors of FGR were explored by multivariate logistic regression analysis, and the fetal outcomes of FGR were analyzed. Results Placenta abnormities [OR(95%CI): 6.259(3.263-12.004)], umbilical cord abnormities [7.500(3.034-18.542)], amniotic fluid abnormities [6.366 (1.050-38.606)], decreased placental area [0.989(0.986-0.992)], hypertension [4.100(2.087-8.055)], anemia [2.387(1.271-4.485)] and increased maternal BMI [1.076 (1.020-1.135)] were independent risk factors for FGR, and the greater the delivery week [0.842(0.728-0.975)], the lower the probability of FGR. The rate of preterm delivery (26.7%), cesarean section (49.6%), fetal distress (18.1%) and fetal mortality (2.9%) in the study group were significantly higher than those in the control group (1.3%, 35.5%, 5.1%, 0%;P<0.05). Conclusions The risk factors for FGR are numerous and interactive which increases the risk of adverse fetal outcomes. Early screening of FGR, monitoring during pregnancy, prevention and treatment of pregnancy complications during pregnancy should be strengthened to improve maternal and fetal outcomes.

Key words： fetal growth restriction risk factors fetal appendages gestational hypertension fetal outcome

Received: 19 July 2024

ZTFLH:

R714

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	XIAO Rou
	HU Lingyun
	WANG Xiaoping
	ZHAO Qingdong
	XIE Xiaoxiao
	YOU Yanqin

Cite this article:

XIAO Rou,HU Lingyun,WANG Xiaoping等. Risk factors of fetal growth restriction in single pregnancy and its influence on fetal outcomes[J]. Med. J. Chin. Peop. Armed Poli. Forc., 2024, 35(11): 944-947.

URL:

https://journal08.magtechjournal.com/Jwk_wjyx/EN/ OR https://journal08.magtechjournal.com/Jwk_wjyx/EN/Y2024/V35/I11/944

[1]	段涛, 杨慧霞, 胡娅莉, 等. 胎儿生长受限专家共识(2019版)[J]. 中国产前诊断杂志(电子版), 2019, 11(4): 78-98.
[2]	Damhuis S E, Ganzevoort W, Gordijn S J. Abnormal fetal growth: small for gestational age, fetal growth restriction, large for gestational age: definitions and epidemiology [J]. Obstet Gynecol Clin North Am, 2021, 48(2): 267-279.
[3]	史慧丽. 胎儿生长受限的影响因素分析[D]. 郑州:郑州大学, 2017.
[4]	苗治晶, 怀莹莹, 吴虹, 等. 胎儿生长受限预测方法的研究进展[J]. 现代妇产科进展, 2015, 24(4): 315-317.
[5]	Darendeliler F. IUGR: Genetic influences, metabolic problems, environmental associations/triggers, current and future management [J]. Best Pract Res Clin Endocrinol Metab, 2019, 33(3): 101260.
[6]	焦立媛, 王华, 武硕. 胎儿生长受限的病因研究进展[J]. 国际妇产科学杂志, 2018, 45(1): 10-13.
[7]	Cnattingius S, Kramer M S, Norman M, et al. Investigating fetal growth restriction and perinatal risks in appropriate for gestational age infants: using cohort and within-sibling analyse [J]. Bjog, 2019, 126(7): 842-850.
[8]	吴小雅, 陈宇清. 胎儿生长受限影响因素及妊娠结局分析[J]. 中国医药科学, 2021, 11(21): 138-141.
[9]	林建华, 吕鑫. 妊娠期高血压疾病的处理难点和困惑——妊娠期高血压疾病诊治指南(2020)解读[J]. 四川大学学报(医学版), 2022, 53(6): 1007-1011.
[10]	吴炜林, 曹臻. 妊娠期铁缺乏和缺铁性贫血对母胎影响的研究进展[J]. 现代预防医学, 2016, 43(21): 3892-3895.
[11]	李云端, 刘伟武, 徐秀英. 影响临床胎儿生长受限的多因素分析及预防措施[J]. 实用临床医药杂志, 2017, 21(1): 90-93.
[12]	王丽丽, 田颖, 鲁莉萍. 孕前体重指数与孕期体重增长对孕妇妊娠期糖尿病发病及妊娠结局的影响[J]. 中国妇幼保健, 2019, 34(1): 62-64.
[13]	刘银春, 朱丽英, 黄映春, 等. 不同孕前体重指数及孕期体重指数增长对妊娠结局的影响[J]. 吉林医学, 2018, 39(3): 423-425.
[14]	何莹婷. 孕前体重指数及孕期体重增长对妊娠结局及新生儿健康的影响[J]. 白求恩医学杂志, 2019, 17(6): 552-554.
[15]	宋诗平, 李静. 妊娠期甲状腺疾病的研究进展[J]. 临床内科杂志, 2019, 36(8): 505-507.
[16]	周丽红. 小于胎龄儿的相关影响因素及妊娠结局分析[D]. 呼和浩特:内蒙古医科大学, 2023.
[17]	刘洪慧. 胎儿生长受限的相关因素分析[J]. 系统医学, 2020, 5(14): 106-108.
[18]	Pineles B L, Crimmins S, Turan O. Timing of delivery in pregnancies complicated by suspected fetal growth restriction without doppler abnormalities [J]. Am J Perinatol, 2020, 37(6): 647-651.
[19]	雷桔红. 134例胎儿生长受限的高危因素及妊娠结局分析[J]. 齐齐哈尔医学院学报, 2019, 40(16): 2022-2025.
[20]	姬力群, 盛晓滨, 林经萍, 等. 胎儿生长受限的原因分析和孕妇分娩方式的选择[J]. 临床医学研究与实践, 2021, 6(23): 30-32.
[21]	毕石磊, 张丽姿, 陈敦金. 胎儿生长受限的围分娩期监测[J]. 中国实用妇科与产科杂志, 2019, 35(4): 403-407.